Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.34.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.106NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.8.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDPNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used